Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Replimune’s IPO

July 25, 2018

Cravath represented the underwriters, J.P. Morgan Securities, Leerink Partners and BMO Capital Markets, in connection with the $111 million initial public offering of the common stock of Replimune Group, Inc., a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform. The shares were listed on the Nasdaq Global Select Market. The transaction closed on July 24, 2018.

The Cravath team included partner William V. Fogg and associates William F. Roegge and Ana Drmanovic on securities matters; partner David J. Kappos and practice area attorney Anthony N. Magistrale on intellectual property matters; associate Kiran Sheffrin on tax matters; and associate Philip F. Schreiber on executive compensation and benefits matters. Summer associate Benjamin J. Barocas also worked on securities matters.

Related Practices & Industries

  • Corporate
  • Capital Markets
  • Intellectual Property
  • Tax
  • Executive Compensation and Benefits
  • Healthcare and Life Sciences

People

Photo
Name
William V. Fogg
Title
Corporate
Title
Partner
Email
wfogg@cravath.com
Phone
+1-212-474-1131
vCard
Download vCard

    Education

    • J.D., 1991, Columbia Law School
      Harlan Fiske Stone Scholar
    • A.B., 1988, Brown University
      magna cum laude

    Admitted In

    • New York
    Photo
    Name
    David J. Kappos
    Title
    Corporate
    Title
    Partner
    Email
    dkappos@cravath.com
    Phone
    +1-212-474-1168
    vCard
    Download vCard

      Education

      • J.D., 1990, University of California, Berkeley, School of Law
      • B.S., 1983, University of California, Davis
        summa cum laude

      Admitted In

      • New York
      • California
      • District of Columbia

      Related News & Insights

      Deals & Cases

      February 12, 2025

      Smithfield Foods, Inc.’s IPO

      Cravath represented the underwriters in connection with the $521.7 million initial public offering of common stock of Smithfield Foods, Inc., an American food company and an industry leader in value‑added packaged meats and fresh pork. The shares were listed on the Nasdaq Global Select Market. The transaction closed on January 29, 2025.

      Deals & Cases

      December 13, 2024

      Groupe Dynamite, Inc.’s IPO

      Cravath represented the underwriters, as U.S. counsel, in connection with the approximately C$313.6 million Rule 144A/Reg. S initial public offering of subordinate voting shares of Groupe Dynamite, Inc., a fashion house that operates retail stores and e‑commerce platforms under two complementary and spirited banners: Garage and Dynamite. The shares were listed on the Toronto Stock Exchange. The transaction closed on November 26, 2024.

      Deals & Cases

      April 15, 2024

      Douglas AG’s IPO

      Cravath, together with Hengeler Mueller, represented Douglas AG in connection with its €890 million initial public offering of ordinary bearer shares. The DOUGLAS Group is a leading omnichannel premium beauty destination in Europe. The shares were listed on the Frankfurt Stock Exchange (Prime Standard). The transaction closed on March 25, 2024.

      Cravath Bicentennial

      Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

      Explore

      Cravath, Swaine & Moore LLP Logo
      • CONTACT US
      • OUR STORY
      • ALUMNI PORTAL
      • DISCLAIMERS & NOTICES

      Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.